grant

Veverimer to decrease net acid excretion and bone resorption in adults with osteopenia: a dose-finding randomized controlled trial

Organization TUFTS MEDICAL CENTERLocation BOSTON, UNITED STATESPosted 10 Aug 2025Deadline 31 Jul 2028
NIHUS FederalResearch GrantFY202521+ years oldACE InhibitorsAcid-Base BalanceAcid-Base EquilibriumAcidsAdultAdult HumanAdverse effectsAgeAlkaliesAngiotensin I-Converting Enzyme InhibitorsAngiotensin-Converting Enzyme AntagonistsAngiotensin-Converting Enzyme InhibitorsAnimalsAnti-Hypertensive AgentsAnti-Hypertensive DrugsAnti-HypertensivesArchitectureBaking SodaBicarbonatesBindingBlood SerumBone FormationBone ResorptionBuffersC-telopeptideCO2CTXCYCLO-cellCapsulesCarbon DioxideCarbonic Acid Monosodium SaltCarbonic AnhydrideCarloxanCerealsChronic Kidney FailureChronic Renal DiseaseChronic Renal FailureCiclofosfamidaCiclofosfamideCicloxalClafenClapheneClinicalClinical TrialsConduct Clinical TrialsConsumptionCycloblastinCycloblastineCyclophosphamCyclophosphamideCyclophosphamidumCyclophosphanCyclophosphaneCyclophosphanumCyclostinCyclostineCytophosphanCytophosphaneCytoxanDataDevelopmentDietDisease ProgressionDoseDrugsEndoxanEndoxanaEnduxanEngineering / ArchitectureExcretory functionFecesFosfaseronFutureG Protein-Coupled Receptor 68GPR68GPR68 geneGenoxalGenuxalGlassGlomerular Filtration RateGrainH+ elementHCO3Hydrochloric AcidHydrogen CarbonatesHydrogen ChlorideHydrogen IonsHydrogen OxideHyperpotassemiaHypertensionHypotensive AgentHypotensive DrugsImpairmentIngestionIntakeIntermediary MetabolismIntestinalIntestinesK elementKHCO3KidneyKidney Urinary SystemKininase II AntagonistsKininase II InhibitorsLaboratoriesLedoxinaMeasuresMedicationMetabolic ProcessesMetabolic acidosisMetabolismMethodsMitoxanModernizationMolecular InteractionMuriatic AcidN-terminalNH2-terminalNa elementNeosarOGR1OralOsteoclastic Bone LossOsteoclastsOsteogenesisOsteopeniaOsteoporosisOsteoporotic riskOutcomeOvarian Cancer G Protein-Coupled Receptor 1ParticipantPharmaceutical PreparationsPhasePlacebosPlant ResinsPolymersPopulationPotassiumProcessProcess AssessmentProcytoxProductionProteinsProtonsRandomizedRandomized Controlled Clinical TrialsRandomized, Controlled TrialsReceptor ProteinRecommendationRenal functionRiskSafetySaltsSample SizeScheduleSendoxanSerumSham TreatmentSodiumSodium BicarbonateSodium Hydrogen CarbonateStomachSyklofosfamidTestingTubularTubular formationType I ProcollagenUrineVascular Hypertensive DiseaseVascular Hypertensive DisorderWaterZytoxanadult youthadulthoodage associatedage associated declineage correlatedage dependentage dependent declineage linkedage relatedage related declineage specificagesanti-hypertensionbonebone cellbone healthbone lossbone massbone tissue formationbowelcapsulechronic kidney diseasedecline with agedesigndesigningdevelopmentaldietarydietary excessdietary guidelinesdietsdrug/agentexcretionfallsfracture riskfruits and vegetablesgastricgastrointestinalgastrointestinal symptomhigh blood pressurehigh riskhyperkalemiahyperpiesiahyperpiesishypertensive diseasehypertensive disorderingestkidney functionlater in lifelater lifemid lifemid-lifemiddle agemiddle agedmidlifenovelolder adultolder adulthoodosteoporosis riskpolymerpolymericpotassium bicarbonatepotassium hydrocarbonatepreservationpreventpreventingrandomisationrandomizationrandomized control clinical trialrandomized control trialrandomly assignedreceptorrecruitrenalresinresponserisk developing osteoporosisrisk factor for osteoporosissham therapystoolurinarywestern dietwestern-style dietwestern-type dietyoung adultyoung adult ageyoung adulthood
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
Starting in mid-life, bone resorption rises and exceeds bone formation – a process that leads to progressive loss

of bone mass, destruction of bone architecture, and ultimately an increased risk of fracture later in life. Acid-

producing diets, such as the modern Western diet, have been implicated as contributors to increased bone…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Veverimer to decrease net acid excretion and bone resorption in adults with osteopenia: a dose-finding randomized contro | Dev Procure